ESSA Pharma Insiders Establish Automatic Securities Disposition Plans

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, Canada, Aug. 31, 2023 /PRNewswire/ – ESSA Pharma Inc. (Nasdaq: EPIX) (“ESSA” or the “Company”), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that each of its…

Click here to view original post